Metabolites and lipid species mediate the associations of adiposity in childhood and early adulthood with mammographic breast density in premenopausal women

被引:0
作者
Getz, Kayla R. [1 ]
Jeon, Myung Sik [1 ,2 ]
Liu, Lili [3 ]
Liu, Lei [3 ]
Zhang, Haixiang [4 ]
Luo, Chongliang [1 ,2 ]
Luo, Jingqin [1 ,2 ]
Toriola, Adetunji T. [1 ,5 ]
机构
[1] Washington Univ, Dept Surg, Div Publ Hlth Sci, Sch Med, Box 8100, 660 South Euclid Ave, St Louis, MO 63110 USA
[2] Washington Univ, Siteman Canc Ctr Biostat Shared Resource, Sch Med, Dept Surg,Div Publ Hlth Sci, St Louis, MO USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO USA
[4] Tianjin Univ, Ctr Appl Math, Tianjin 300072, Peoples R China
[5] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO 63110 USA
关键词
Early-life; Age; 10; 18; Body mass index; Lipidomics; Mammographic breast density; Metabolomics; Premenopausal; BODY-MASS INDEX; PHYSICAL-ACTIVITY; OBESITY; METABOLOMICS; DISEASE; WEIGHT;
D O I
10.1186/s13058-025-01970-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Mammographic breast density (MBD), a strong predictor of breast cancer, is highly influenced by body mass index (BMI) in childhood and early adulthood, but the mechanisms underlying these associations are not fully understood. Our goal is to identify biomarkers that mediate the associations of BMI at ages 10 and 18 with MBD in premenopausal women. Methods This study consists of 705 premenopausal women who had their screening mammogram at Washington University in St. Louis, MO, and provided a fasting blood sample. Our comprehensive metabolomic and lipidomic profiling yielded complete data for 828 metabolites and 857 lipid species after imputation. We used Volpara to determine volumetric measures of MBD. We performed high dimensional mediation analysis using the HIMA R package, adjusted for confounders, to determine whether lipid species and metabolites mediate the associations of BMI at 10 and 18 with MBD. We applied a false discovery rate (FDR) p-value < 0.1. Results Four metabolites (glutamate, (3-cryptoxanthin, cortolone glucuronide (1), phytanate) significantly mediated the association of BMI at 10 with volumetric percent density (VPD), and two (glutamate, (3-cryptoxanthin) mediated the association of BMI at 18 with VPD. Glutamate was the strongest mediator across time points. Glutamate mediated 6.7% (FDR p-value = 0.06) and 9.3% (FDR p-value = 0.008) of the association between BMI at age 10 and 18, respectively. Four lipid species (CER(18:0), LCER(14:0), LPC(18:1), PC(18:1/18:1)), mediated the association of BMI at 10 with VPD, while five lipid species (CER(18:0), LCER(14:0), PC(18:1/18:1),TAG56:5-FA22:5,TAG52:2-FA16:0) mediated the association of BMI at 18 with VPD.The strongest mediator was PC(18:1/18:1), which mediated 9.7%, (FDR-p= 0.009) and 7.7%, (FDR-p = 0.04) of the association of BMI at age 10 and 18 with VPD, respectively. Conclusions Metabolites in amino acid, lipid, cofactor/vitamin, and xenobiotic super-pathways as well as lipid species across the phospholipid, neutral complex lipid and sphingolipid super-pathways mediated the associations of BMI in early-life and MBD in premenopausal women. This study offers insight into the biological mechanisms underlying the link between early-life adiposity and MBD, which can support future research into breast cancer prevention.
引用
收藏
页数:12
相关论文
共 34 条
  • [31] Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial
    Yang, H.
    Zong, X.
    Yu, Y.
    Shao, G.
    Zhang, L.
    Qian, C.
    Bian, Y.
    Xu, X.
    Sun, W.
    Meng, X.
    Ding, X.
    Chen, D.
    Zou, D.
    Xie, S.
    Zheng, Y.
    Zhang, J.
    He, X.
    Sun, C.
    Yu, X.
    Ni, J.
    BRITISH JOURNAL OF CANCER, 2013, 109 (03) : 582 - 588
  • [32] Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial
    H Yang
    X Zong
    Y Yu
    G Shao
    L Zhang
    C Qian
    Y Bian
    X Xu
    W Sun
    X Meng
    X Ding
    D Chen
    D Zou
    S Xie
    Y Zheng
    J Zhang
    X He
    C Sun
    X Yu
    J Ni
    British Journal of Cancer, 2013, 109 : 582 - 588
  • [33] Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
    Fogelman, I
    Blake, GM
    Blamey, R
    Palmer, M
    Sauerbrei, W
    Schumacher, M
    Serin, D
    Stewart, A
    Wilpshaar, W
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 (12) : 1001 - 1006
  • [34] Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
    I. Fogelman
    G. M. Blake
    R. Blamey
    M. Palmer
    W. Sauerbrei
    M. Schumacher
    D. Serin
    A. Stewart
    W. Wilpshaar
    Osteoporosis International, 2003, 14 : 1001 - 1006